Shilpa Medicare Ltd 2019 AR2
The report outlines Shilpa Medicare Limited's financial and operational performance for the fiscal year 2018-19. The company achieved standalone revenues of ₹ 67,966.86 Lakhs, with its formulations business showing strong growth to ₹ 16,600.69 Lakhs. Key highlights include the upgrade of its Oral Thin Films facility in Hyderabad to European regulatory standards and the near completion of a world-class biologics manufacturing facility in Dharwad, Karnataka. Additionally, the company advanced its sustainability efforts through the Shilpa Foundation, focusing on water conservation, education, and tree plantation.
Company: Shilpa Medicare Ltd
Sector: Manufacturing
Country: India
Year: 2019
Type: AR2
Pages: 193
Shilpa Medicare Ltd
The report outlines Shilpa Medicare Limited's financial and operational performance for the fiscal year 2018-19. The company achieved standalone revenues of ₹ 67,966.86 Lakhs, with its formulations business showing strong growth to ₹ 16,600.69 Lakhs. Key highlights include the upgrade of its Oral Thin Films facility in Hyderabad to European regulatory standards and the near completion of a world-class biologics manufacturing facility in Dharwad, Karnataka. Additionally, the company advanced its sustainability efforts through the Shilpa Foundation, focusing on water conservation, education, and tree plantation.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Apr 1, 2018 - Mar 31, 2019
Fiscal Year
2019
Published
Aug 29, 2019
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees